Convergence Investment Partners LLC Takes $217,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

Convergence Investment Partners LLC bought a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 2,262 shares of the company's stock, valued at approximately $217,000.

Other institutional investors have also recently modified their holdings of the company. Creative Planning raised its holdings in shares of HealthEquity by 18.6% during the third quarter. Creative Planning now owns 23,632 shares of the company's stock valued at $1,934,000 after purchasing an additional 3,706 shares during the last quarter. Raymond James & Associates grew its position in HealthEquity by 1.3% in the 3rd quarter. Raymond James & Associates now owns 151,318 shares of the company's stock worth $12,385,000 after purchasing an additional 1,911 shares during the period. Sequoia Financial Advisors LLC raised its stake in HealthEquity by 2.3% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 13,314 shares of the company's stock valued at $1,090,000 after buying an additional 303 shares during the last quarter. Private Advisor Group LLC bought a new position in shares of HealthEquity during the 3rd quarter valued at $208,000. Finally, Wealth Enhancement Advisory Services LLC boosted its stake in shares of HealthEquity by 18.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 3,649 shares of the company's stock worth $299,000 after buying an additional 578 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HealthEquity

In related news, Director Stuart B. Parker sold 25,000 shares of the business's stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares of the company's stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 39,000 shares of company stock valued at $3,895,788 in the last three months. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Price Performance

HealthEquity stock traded down $3.47 during mid-day trading on Friday, hitting $108.25. The stock had a trading volume of 261,776 shares, compared to its average volume of 720,651. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm's 50 day moving average is $103.40 and its 200 day moving average is $91.77. The firm has a market capitalization of $9.38 billion, a P/E ratio of 99.42, a P/E/G ratio of 1.63 and a beta of 0.55. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the firm posted $0.40 EPS. On average, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. BTIG Research upped their price objective on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday, November 14th. The Goldman Sachs Group initiated coverage on shares of HealthEquity in a research note on Friday, November 15th. They issued a "neutral" rating and a $108.00 price objective on the stock. Bank of America raised their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a report on Wednesday, November 13th. Mizuho began coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 target price for the company. Finally, Royal Bank of Canada lifted their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $110.71.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.